Overview
We are ranked among one of the best children's hospitals in the country for pediatric neurology and neurosurgery, according to U.S. News & World Report. We combine our expertise of diagnosing and treating disorders of the nervous system with an understanding of childhood medical disorders and the special needs of children and their families.
Specialized care for kids.
If your child has problems involving the nervous system, we have the special training and experience to treat him. In many cases, we work as a team with pediatricians and other primary care doctors. We also work closely with other pediatric specialists as needed, such as behavioral and neuropsychologists, developmental and behavioral pediatricians and pediatric neurosurgeons, to care for children who have more complex or serious medical issues. These include epilepsy, birth defects and mental retardation.
We use a variety of tests and procedures to obtain an accurate diagnosis, such as cerebral angiography, EEG, EMG, nerve conduction velocity testing and transcranial Doppler. We may also use neuropsychological testing to assess cognitive development and function.
We stay up on the latest advances in the treatment of neurologic conditions, such as a ketogenic diet for reducing the number of seizures associated with epilepsy or cognitive behavioral therapy and biofeedback training for managing chronic headaches, to ensure your child gets the most effective and up-to-date therapies to meet her individual needs.
Conditions we treat.
Among the range of conditions we diagnose and treat are:
- Seizure disorders, including seizures in newborns, febrile convulsions and epilepsy
- Medical aspects of head injuries and brain tumors
- Weakness, including cerebral palsy, muscular dystrophy and neuromuscular disorders
- Headaches, including migraines
- Behavioral disorders, including attention-deficit/hyperactivity disorder (ADHD), school failure, autism and sleep problems
- Developmental disorders, including delayed speech or motor milestones, and coordination issues
- Intellectual disability (formerly called mental retardation)
- Hydrocephalus
- Metabolic and mitochondrial diseases
Locations/Contact Us
Contact Neurology
Akron Children's Hospital
NeuroDevelopmental Science Center
215 W. Bowery St.
Suite 4400
Akron, Ohio 44308
Fax: 330-543-8054
More about this location...
Map & directions
Akron Children's Hospital Specialty Care
6505 Market St., Building A
Boardman, Ohio 44512
Fax: 330-729-1144
More about this location...
Map & directions
Akron Children's Health Center, North Canton
6076 Whipple Ave
North Canton, Ohio 44720
More about this location...
Map & directions
Akron Children's Hospital Specialty Care
3443 Medina Road, Door 1 (Suite 108)
Medina, Ohio 44256
More about this location...
Map & directions
Akron Children's Hospital Specialty Care
Fisher-Titus Medical Center
282 Benedict Ave.
Norwalk, Ohio 44857
More about this location...
Map & directions
Akron Children's Hospital Specialty Care
The Market Place
5000 E. Market St.
Warren, Ohio 44484
More about this location...
Map & directions
Our Doctors/Providers
Director, Pediatric Neurology; Pediatric Neurologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Nurse Practitioner
Director, Tuberous Sclerosis Clinic, Pediatric Neurologist
Director, NeuroDevelopmental Science Center; Pediatric Neurologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Nurse Practitioner
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Neurologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Coordinator, Epilepsy Surgery Program; Pediatric Nurse Practitioner
Pediatric Neurologist
Pediatric Neurologist
Pediatric Nurse Practitioner
Pediatric Neurologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Neurologist/Epileptologist
Advanced Practice Provider, Inpatient NeuroDevelopmental Science Center
Pediatric Nurse Practitioner
Pediatric Neurologist
Pediatric Neurologist
Pediatric Neurologist
Director, Headache Program; Pediatric Neurologist
Director, Pediatric Epileptology; Pediatric Neurologist/Epileptologist
Clinics
Open Clinical Studies
Safety and efficacy of pregabalin in children 4-16 years old with partial onset seizures
Epilepsy is often controlled by current medications. For some children, however, these medicines do not fully control their seizures. Or, these medicines may cause side effects. In this study we want to find out if a medicine (pregabalin) helps reduce partial onset seizures in children. If your child already takes antiepileptic drugs but still has seizures, we will give pregabalin as an add-on medication. Some children may receive a pill without an active drug (a placebo). We can then determine if adding pregabalin reduced seizures.
Currently recruiting
Safety and efficacy of pregabalin in children 1 mo-<4 years with partial onset seizures
Epilepsy is often controlled by current medications. For some children, however, these medicines do not fully control their seizures. Or, these medicines may cause side effects. In this study we want to find out if a medicine (pregabalin) helps reduce partial onset seizures in children. If your child already takes antiepileptic drugs but still has seizures, we will give pregabalin as an add-on medication. Some children may receive a pill without an active drug (a placebo). We can then determine if adding pregabalin reduced seizures.
Currently recruiting
How children and adults with mitochondrial myopathy respond to exercise
We’re trying to learn how people with mitochondrial myopathy respond to exercise. Mitochondria are the body’s "power plants." They turn food into energy. If the "power plants” don’t make enough energy, muscles may grow weak. We’re studying differences between mitochondrial myopathy patients and healthy children when exercising. An exercise test tells us about breathing, blood circulation and muscle function during exercise. Such studies may lead to exercise testing as a way to diagnose and monitor mitochondrial myopathy patients.
Currently recruiting
Alpers Huttenlocher Natural History Study (Alpers)
We are conducting this study to understand the history of AHS, a rare genetic disorder that is characterized by seizures, liver dysfunction and progressive developmental regression that leads to early death. Through this study we will determine if there are connections between a patient’s medical history and onset of AHS as well as the relationship between signs and symptoms of presentation of AHS and severity and survival of AHS. Children born with this disorder will appear heathy at birth and usually develop normally until the onset of their illness. Most patients with AHS will show symptoms of this illness between 2-4 years of age and a smaller group of patients show symptoms for between 17-24 years of age. For more information on the Alpers-HuttenLocher Syndrome, visit: https://ghr.nlm.nih.gov/condition/alpers-huttenlocher-syndrome#diagnosis For complete study information, visit: https://clinicaltrials.gov/ct2/show/NCT03034512?term=alpers-huttenlocher&rank=1
Currently recruiting
Lacosamide as Therapy in Patients with Epilepsy
For complete study information, please visit clinicaltrials.gov.
Currently recruiting
Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status
For complete study information, please visit clinicaltrials.gov.
Currently recruiting
Safety and Efficacy of Perampanel in Children 1 month to 2 years
For complete study information, please view the study on clinicaltrials.gov
Currently recruiting
Safety and Efficacy of Pregabalin in Children Aged 1 mo to 16 years with Seizures
For complete information, please view the study on clinicaltrials.gov
Currently recruiting
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
For complete information, please view the study on clinicaltrials.gov
Currently recruiting
Study of Cognitive effects of antiepileptic drugs in children with new-onset seizures
Epilepsy is the most common neurologic disorder in children affecting 4-6 per 1000 children Antiepileptic drugs (AEDs) are the primary, and frequently exclusive, treatment option for epilepsy. While necessary and effective for seizure control, AEDs can also cause neurotoxicity, adversely affecting functioning of the central nervous system. This study aims to evaluate patients before starting AED’s to evaluate any possible side effects or difference in the child’s ability to perform certain tasks (cognitive functioning) The purpose of the proposed study is to examine the cognitive and behavioral effects of commonly prescribed AEDs on children with new onset seizures. This will be accomplished by recruiting children who are seen in the new onset seizure clinic in the Neurology service of the Neuro Developmental Science Center (NDSC) at Akron Children’s Hospital.
Currently recruiting
Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP
See complete study information on clinicaltrials.gov.
Currently recruiting
Videos
